Roche reports promising results from anti-COVID cocktail
Swiss pharma giant Roche announced Tuesday promising results from clinical trials of an anti-COVID cocktail developed with US biotech firm Regeneron.
Mar 23, 2021
0
24
Swiss pharma giant Roche announced Tuesday promising results from clinical trials of an anti-COVID cocktail developed with US biotech firm Regeneron.
Mar 23, 2021
0
24
Swiss pharmaceuticals giant Roche said Thursday it is collaborating with Atea Pharmaceuticals on the development of an orally administered drug to treat coronavirus patients who have not been hospitalised.
Oct 22, 2020
0
4
Roche, the world's top cancer drug maker, announced Friday it had agreed to buy US firm Ignyta, which is developing a treatment against some tumours, for $1.7 billion (1.4 billion euros).
Dec 22, 2017
0
3
The breast cancer drug trastuzumab emtansine (also known as Kadcyla) will not be made routinely available on the NHS following a failure to reach an agreement on price between the National Institute for Health and Care Excellence ...
Aug 11, 2014
0
0
(HealthDay) -- In older patients with mantle-cell lymphoma, a rituximab-based chemotherapy regimen (rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone [R-CHOP]) followed by maintenance therapy with rituximab ...
Aug 9, 2012
0
0
Swiss pharmaceutical giant Roche is under investigation over a failure to properly report adverse drug side-effects, the European Medicines Agency (EMA) said on Thursday.
Jun 21, 2012
0
0
Researchers at the Hebrew University of Jerusalem have identified the key signal that prompts production of insulin-producing beta cells in the pancreas -- a breakthrough discovery that may ultimately help researchers find ...
Sep 12, 2011
0
0